NASDAQ:CVAC

CureVac News Headlines

$100.40
+6.45 (+6.87 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$98.32
▼
$104.00
50-Day Range
$83.65
▼
$127.53
52-Week Range
$36.15
▼
$151.80
Volume1.51 million shs
Average Volume970,166 shs
Market Capitalization$18.77 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

CureVac (NASDAQ CVAC) News Headlines Today

SourceHeadline
These four COVID-19 vaccines could soon join the pandemic fightThese four COVID-19 vaccines could soon join the pandemic fight
finance.yahoo.com - May 8 at 12:56 PM
CureVac (NASDAQ:CVAC) Shares Gap Up to $93.95CureVac (NASDAQ:CVAC) Shares Gap Up to $93.95
americanbankingnews.com - May 7 at 11:08 AM
CureVac (NASDAQ:CVAC) Shares Gap Down to $101.20CureVac (NASDAQ:CVAC) Shares Gap Down to $101.20
americanbankingnews.com - May 6 at 2:06 PM
UPDATE 2-Drugmakers say Biden misguided over vaccine patent waiverUPDATE 2-Drugmakers say Biden misguided over vaccine patent waiver
finance.yahoo.com - May 6 at 1:38 PM
Elizabeth Warren responds to Bidens backing of COVID-19 vaccine patent waivers: Im delightedElizabeth Warren responds to Biden's backing of COVID-19 vaccine patent waivers: 'I'm delighted'
finance.yahoo.com - May 6 at 1:38 PM
Stocks near record highs on recovery hopes, Curevac sinks - ReutersStocks near record highs on recovery hopes, Curevac sinks - Reuters
reuters.com - May 6 at 8:37 AM
CureVac N.V. (NASDAQ:CVAC) On The Verge Of Breaking Even - Yahoo FinanceCureVac N.V. (NASDAQ:CVAC) On The Verge Of Breaking Even - Yahoo Finance
finance.yahoo.com - May 5 at 12:36 PM
CureVac says well on track to request vaccine approval as planned - ReutersCureVac says well on track to request vaccine approval as planned - Reuters
reuters.com - May 5 at 12:36 PM
CureVac N.V. (NASDAQ:CVAC) On The Verge Of Breaking EvenCureVac N.V. (NASDAQ:CVAC) On The Verge Of Breaking Even
finance.yahoo.com - May 5 at 12:36 PM
CureVac says mass vaccine rollout thrown into doubt by U.S. restrictions - ReutersCureVac says mass vaccine rollout thrown into doubt by U.S. restrictions - Reuters
reuters.com - May 4 at 3:37 PM
CureVac (NASDAQ:CVAC) Sees Significant Growth in Short InterestCureVac (NASDAQ:CVAC) Sees Significant Growth in Short Interest
americanbankingnews.com - May 4 at 3:06 PM
CureVac (NASDAQ:CVAC) Shares Down 10.5% CureVac (NASDAQ:CVAC) Shares Down 10.5%
americanbankingnews.com - May 4 at 1:16 PM
What to Expect From Novavax and CureVac Covid-19 Vaccines - BloombergWhat to Expect From Novavax and CureVac Covid-19 Vaccines - Bloomberg
bloomberg.com - May 3 at 1:21 PM
CureVac (NASDAQ:CVAC) Coverage Initiated at GuggenheimCureVac (NASDAQ:CVAC) Coverage Initiated at Guggenheim
americanbankingnews.com - May 3 at 10:10 AM
Comparing Albireo Pharma (NASDAQ:ALBO) & CureVac (NASDAQ:CVAC)Comparing Albireo Pharma (NASDAQ:ALBO) & CureVac (NASDAQ:CVAC)
americanbankingnews.com - May 2 at 8:06 PM
CureVacs Vaccine Might Protect Against the South African Variant - Motley FoolCureVac's Vaccine Might Protect Against the South African Variant - Motley Fool
fool.com - May 1 at 6:09 PM
CureVacs Vaccine Might Protect Against the South African Variant - NasdaqCureVac's Vaccine Might Protect Against the South African Variant - Nasdaq
nasdaq.com - May 1 at 1:09 PM
CureVacs Vaccine Might Protect Against the South African VariantCureVac's Vaccine Might Protect Against the South African Variant
fool.com - May 1 at 11:25 AM
CureVac: Last Call For Investors Before Likely Positive COVID Vaccine Data Drops - Seeking AlphaCureVac: Last Call For Investors Before Likely Positive COVID Vaccine Data Drops - Seeking Alpha
seekingalpha.com - April 29 at 3:58 PM
CureVac (NASDAQ:CVAC) Coverage Initiated at Credit Suisse GroupCureVac (NASDAQ:CVAC) Coverage Initiated at Credit Suisse Group
americanbankingnews.com - April 28 at 2:34 PM
CureVac (NASDAQ:CVAC) Shares Gap Up to $127.53CureVac (NASDAQ:CVAC) Shares Gap Up to $127.53
americanbankingnews.com - April 28 at 11:44 AM
CureVac (NASDAQ:CVAC) Trading 5.3% Higher CureVac (NASDAQ:CVAC) Trading 5.3% Higher
americanbankingnews.com - April 27 at 3:46 PM
Theres Room for More Players in the Covid-19 Vaccine Market, Analyst Says - BarronsThere's Room for More Players in the Covid-19 Vaccine Market, Analyst Says - Barron's
barrons.com - April 26 at 2:58 PM
CureVacs Potential Has Wall Street Sending Mixed Signals - Motley FoolCureVac's Potential Has Wall Street Sending Mixed Signals - Motley Fool
fool.com - April 26 at 2:58 PM
CureVacs Potential Has Wall Street Sending Mixed SignalsCureVac's Potential Has Wall Street Sending Mixed Signals
fool.com - April 26 at 2:35 PM
Guggenheim Initiates Coverage on CureVac (NASDAQ:CVAC)Guggenheim Initiates Coverage on CureVac (NASDAQ:CVAC)
americanbankingnews.com - April 26 at 1:48 PM
CureVac (NASDAQ:CVAC) Receives Consensus Rating of "Hold" from AnalystsCureVac (NASDAQ:CVAC) Receives Consensus Rating of "Hold" from Analysts
americanbankingnews.com - April 26 at 10:02 AM
CureVac: Multiple Potential Catalysts Could Send Shares On An Upward Trajectory - Yahoo FinanceCureVac: Multiple Potential Catalysts Could Send Shares On An Upward Trajectory - Yahoo Finance
finance.yahoo.com - April 22 at 3:37 PM
CureVac: Multiple Potential Catalysts Could Send Shares On An Upward TrajectoryCureVac: Multiple Potential Catalysts Could Send Shares On An Upward Trajectory
finance.yahoo.com - April 22 at 10:37 AM
REFILE-CureVacs shot ready in Europe by May- head of Italys medicines regulator - Yahoo FinanceREFILE-CureVac's shot ready in Europe by May- head of Italy's medicines regulator - Yahoo Finance
finance.yahoo.com - April 21 at 11:15 PM
CureVacs shot ready in Europe by May- head of Italys medicines regulator - NasdaqCureVac's shot ready in Europe by May- head of Italy's medicines regulator - Nasdaq
nasdaq.com - April 21 at 7:56 AM
REFILE-CureVacs shot ready in Europe by May- head of Italys medicines regulatorREFILE-CureVac's shot ready in Europe by May- head of Italy's medicines regulator
finance.yahoo.com - April 21 at 7:56 AM
2 Reasons This COVID Vaccine Latecomer Could Gain Major Market Share2 Reasons This COVID Vaccine Latecomer Could Gain Major Market Share
finance.yahoo.com - April 21 at 7:56 AM
Vaccine Stocks Checkup: Johnson & Johnson Is RisingVaccine Stocks Checkup: Johnson & Johnson Is Rising
finance.yahoo.com - April 20 at 3:03 PM
CureVac (NASDAQ:CVAC) Shares Gap Down to $113.00CureVac (NASDAQ:CVAC) Shares Gap Down to $113.00
americanbankingnews.com - April 20 at 11:38 AM
CureVacs Shot Could Arrive Just in Time - BloombergCureVac's Shot Could Arrive Just in Time - Bloomberg
bloomberg.com - April 19 at 11:32 PM
CureVac starts review process in Switzerland for COVID-19 vaccine hopeful - Yahoo FinanceCureVac starts review process in Switzerland for COVID-19 vaccine hopeful - Yahoo Finance
finance.yahoo.com - April 19 at 8:31 AM
CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with SwissmedicCureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
finance.yahoo.com - April 19 at 8:30 AM
CureVac starts review process in Switzerland for COVID-19 vaccine hopefulCureVac starts review process in Switzerland for COVID-19 vaccine hopeful
finance.yahoo.com - April 19 at 8:30 AM
CureVac says it is on track with COVID-19 vaccine as it posts earnings update - MarketWatchCureVac says it is on track with COVID-19 vaccine as it posts earnings update - MarketWatch
marketwatch.com - April 17 at 11:16 PM
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020 - Yahoo FinanceCureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020 - Yahoo Finance
finance.yahoo.com - April 17 at 7:48 AM
CureVac Sees Unusually High Options Volume (NASDAQ:CVAC)CureVac Sees Unusually High Options Volume (NASDAQ:CVAC)
americanbankingnews.com - April 17 at 2:00 AM
UPDATE 1-CureVacs COVID-19 vaccine attracts rising interest | Financial News - London South EastUPDATE 1-CureVac's COVID-19 vaccine attracts rising interest | Financial News - London South East
lse.co.uk - April 16 at 11:42 AM
CureVac says interest in its COVID-19 vaccine on the rise - ReutersCureVac says interest in its COVID-19 vaccine on the rise - Reuters
reuters.com - April 16 at 11:42 AM
CureVac in Talks With U.S. Over Next-gen Covid Shot: CEO - BloombergCureVac in Talks With U.S. Over Next-gen Covid Shot: CEO - Bloomberg
bloomberg.com - April 16 at 11:42 AM
CureVac (CVAC) Q4 2020 Earnings Call TranscriptCureVac (CVAC) Q4 2020 Earnings Call Transcript
fool.com - April 15 at 11:50 PM
CureVac hopes to win regulatory approval for its Covid vaccine by June - Financial TimesCureVac hopes to win regulatory approval for its Covid vaccine by June - Financial Times
ft.com - April 15 at 10:29 PM
Kempen & Cos Gafanhao on the Curevac Covid-19 Vaccine - BloombergKempen & Co's Gafanhao on the Curevac Covid-19 Vaccine - Bloomberg
bloomberg.com - April 15 at 5:28 PM
CureVac N.V. to Host Earnings Call - Yahoo FinanceCureVac N.V. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - April 15 at 12:27 PM
Inovio and CureVac Surge on Vaccine Candidate Results, J&J Pause - TheStreetInovio and CureVac Surge on Vaccine Candidate Results, J&J Pause - TheStreet
thestreet.com - April 15 at 12:27 PM
This page was last updated on 5/9/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.